UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Kommunikation von Unternehmertum: Eine explorative Untersuchung im universitären Umfeld

1. Aufl., 2006

Volltextzugriff (PDF)

Optimization of cisplatin for the treatment of hormone dependent tumoral diseases

Coordination chemistry reviews, 2009-11, Vol.253 (21), p.2742-2759

2009

Volltextzugriff (PDF)

Optimization of cisplatin for the treatment of hormone-dependent tumoral diseases

Coordination chemistry reviews, 2009-11, Vol.253 (21), p.2760-2779

2009

Volltextzugriff (PDF)

Germany: high-tech region Munich generating the next wave of scalable startups

Global Clusters of Innovation, 2014, p.95-119

Helmut Schönenberger

2014

Volltextzugriff (PDF)

N-Ethyl- and [N,N‘-Diethyl-1,2-bis(2,6-difluoro-3-hydroxyphenyl)- ethylenediamine]dichloroplatinum(II): Structure and Cytotoxic/Estrogenic Activity in Breast Cancer Cells

Journal of medicinal chemistry, 2005-11, Vol.48 (23), p.7132-7144

2005

Volltextzugriff (PDF)

Synthesis and antitumor activity of platinum(II) complexes containing substituted ethylenediamine ligands

European journal of medicinal chemistry, 1990-02, Vol.25 (1), p.35-44

1990

Volltextzugriff (PDF)

Systematic spin-off processes in university–industry ecosystems

Academic Spin-Offs and Technology Transfer in Europe, 2016, p.77-92

2016

Volltextzugriff (PDF)

Platinum (II) complexes interfering with testicular steroid biosynthesis : drugs for the therapy of advanced or recurrent prostate cancers? Preclinical studies

Journal of cancer research and clinical oncology, 2007-03, Vol.133 (3), p.153-167

2007

Volltextzugriff (PDF)

Does [meso-1,2-bis(2,6-dichloro-4-hydroxy-phenyl) ethylenediamine]dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound

Archiv der Pharmazie (Weinheim), 2001-10, Vol.334 (10), p.309-317

2001

Volltextzugriff (PDF)

[Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring

Journal of cancer research and clinical oncology, 2000-10, Vol.126 (11), p.647-654

2000

Volltextzugriff (PDF)

Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity

Journal of cancer research and clinical oncology, 1992, Vol.118 (1), p.35-43

1992

Volltextzugriff (PDF)

[Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring. 3. Investigation of breast cancer inhibiting properties

Journal of cancer research and clinical oncology, 2000-11, Vol.126 (11), p.647-654

2000

Volltextzugriff (PDF)

Stability and cellular studies of [rac-1,2-bis(4-fluorophenyl)-ethylenediamine][cyclobutane-1,1-dicarboxylato]platinum(II), a novel, highly active carboplatin derivative

Journal of cancer research and clinical oncology, 1998, Vol.124 (11), p.585-597

1998

Volltextzugriff (PDF)

Investigation of the Configurational and Conformational Influences on the Hormonal Activity of 1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamines and of their Platinum(II) Complexes. 1. Synthesis, Estradiol Receptor Affinity, and Estrogenic Activity of Diastereomeric [N-Alkyl- and N,N'-Dialkyl-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) Complexes

Journal of medicinal chemistry, 1995-06, Vol.38 (12), p.2070-2079

1995

Volltextzugriff (PDF)

Potentielle Antiöstrogene vom Typ des 1,2-Diphenyl-1-pyridyl-but-1-ens Teil 1: Synthese

Archiv der Pharmazie (Weinheim), 1991, Vol.324 (4), p.223-229

1991

Volltextzugriff (PDF)

Does [meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloro-platinum(II) Act as an Immune Response Modifier? Part III: Progressively Growing MXT-M-3,2 Breast Cancer Stimulates the Proliferation of Phagocytes in B6D2F1 Mice

Archiv der Pharmazie (Weinheim), 2000-12, Vol.333 (12), p.404-414

2000

Volltextzugriff (PDF)

[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer - Mode of Action I: Antitumor Activity Due to the Reduction of the Endogenous Estrogen Level

Archiv der Pharmazie (Weinheim), 2004-06, Vol.337 (6), p.335-348

2004

Volltextzugriff (PDF)

Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanoma

Journal of cancer research and clinical oncology, 1995-04, Vol.121 (4), p.193-202

1995

Volltextzugriff (PDF)

Computerized determination of growth kinetic curves and doubling times from cells in microculture

Analytical biochemistry, 1990-06, Vol.187 (2), p.262-267

1990

Volltextzugriff (PDF)

Potentielle Antiöstrogene vom Typ des 1,2-Diphenyl-1-pyridyl-but-1-ens. Teil 2: Biologische Prüfung

Archiv der Pharmazie (Weinheim), 1991, Vol.324 (4), p.231-234

1991

Volltextzugriff (PDF)

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloroplatinum (II) Act on the Hormone-Sensitive, Murine Breast Cancer as a Biological Response Modifier? Part II. Studies on the Influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) on the Specific Immune Defense in MXT-M-3,2 Breast Cancer Bearing Mice

Archiv der Pharmazie (Weinheim), 2000-12, Vol.333 (12), p.397-403

2000

Volltextzugriff (PDF)

Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo

Journal of cancer research and clinical oncology, 1992-08, Vol.118 (8), p.591-596

1992

Volltextzugriff (PDF)

[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer - Mode of Action II: Contribution of Drug Inactivation, Cellular Drug Uptake and Sterical Factors in the Drug-Target Interaction to the Antitumor Activity

Archiv der Pharmazie (Weinheim), 2004-06, Vol.337 (6), p.349-359

2004

Volltextzugriff (PDF)

[meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a Compound with a Specific Activity on Hormone-Sensitive Breast Cancers - Evidence for a Diethylstilbestrol-Like Mode of Action

Archiv der Pharmazie (Weinheim), 1999-03, Vol.332 (2), p.59-69

1999

Volltextzugriff (PDF)

[ Meso- and rac-1,2-bis(4-fluorophenyl)ethylenediamine]chloro[sulfinylbis(methane)-S]platinum(II) chloride new water soluble platinum complexes with high anti-breast cancer activities

Inorganica Chimica Acta, 1999-02, Vol.285 (2), p.184-189

1999

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(154)

Publikationsform

Sprache

Englisch
(134)
Deutsch
(29)

Erscheinungsjahr

n.n

Thema

Animals
(56)
Science & Technology
(56)
Life Sciences & Biomedicine
(49)
Female
(48)
Mice
(48)
Biological And Medical Sciences
(39)
Humans
(38)
Chemistry
(37)
Medical Sciences
(36)
Pharmacology. Drug Treatments
(34)
Antineoplastic Agents
(33)
Pharmacology & Pharmacy
(29)
Chemistry, Medicinal
(28)
Organoplatinum Compounds - Pharmacology
(27)
Structure-Activity Relationship
(27)
Mammary Neoplasms, Experimental - Drug Therapy
(26)
Antineoplastic Agents - Pharmacology
(24)
General Aspects
(21)
Physical Sciences
(20)
Antineoplastic Agents - Chemical Synthesis
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Kommunikation von Unternehmertum: Eine explorative Untersuchung im universitären Umfeld

Optimization of cisplatin for the treatment of hormone dependent tumoral diseases

Optimization of cisplatin for the treatment of hormone-dependent tumoral diseases

Germany: high-tech region Munich generating the next wave of scalable startups

N-Ethyl- and [N,N‘-Diethyl-1,2-bis(2,6-difluoro-3-hydroxyphenyl)- ethylenediamine]dichloroplatinum(II): Structure and Cytotoxic/Estrogenic Activity in Breast Cancer Cells

Synthesis and antitumor activity of platinum(II) complexes containing substituted ethylenediamine ligands

Systematic spin-off processes in university–industry ecosystems

Platinum (II) complexes interfering with testicular steroid biosynthesis : drugs for the therapy of advanced or recurrent prostate cancers? Preclinical studies

Does [meso-1,2-bis(2,6-dichloro-4-hydroxy-phenyl) ethylenediamine]dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound

[Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring

Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity

[Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring. 3. Investigation of breast cancer inhibiting properties

Stability and cellular studies of [rac-1,2-bis(4-fluorophenyl)-ethylenediamine][cyclobutane-1,1-dicarboxylato]platinum(II), a novel, highly active carboplatin derivative

Potentielle Antiöstrogene vom Typ des 1,2-Diphenyl-1-pyridyl-but-1-ens Teil 1: Synthese

Does [meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloro-platinum(II) Act as an Immune Response Modifier? Part III: Progressively Growing MXT-M-3,2 Breast Cancer Stimulates the Proliferation of Phagocytes in B6D2F1 Mice

[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer - Mode of Action I: Antitumor Activity Due to the Reduction of the Endogenous Estrogen Level

Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanoma

Computerized determination of growth kinetic curves and doubling times from cells in microculture

Potentielle Antiöstrogene vom Typ des 1,2-Diphenyl-1-pyridyl-but-1-ens. Teil 2: Biologische Prüfung

Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo

[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer - Mode of Action II: Contribution of Drug Inactivation, Cellular Drug Uptake and Sterical Factors in the Drug-Target Interaction to the Antitumor Activity

[meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a Compound with a Specific Activity on Hormone-Sensitive Breast Cancers - Evidence for a Diethylstilbestrol-Like Mode of Action

[ Meso- and rac-1,2-bis(4-fluorophenyl)ethylenediamine]chloro[sulfinylbis(methane)-S]platinum(II) chloride new water soluble platinum complexes with high anti-breast cancer activities

Suchergebnisse filtern